Literature DB >> 8877195

Retroviral p15E-related serum factors and recurrence of head and neck cancer.

M P Tas1, D Laarman, M D Haan-Meulman, A J Balm, G B Snow, H A Drexhage.   

Abstract

Surgical removal of head and neck squamous cell carcinoma (HNSCC) restores the defective monocyte polarization found in patients with HNSCC. Since HNSCC contain p15E-like low molecular weight factors < 25 kD (LMWF) capable of suppressing N-formyl-methionyl-leucylphenylalanine (fMLP)-induced monocyte polarization, it is likely that HNSCC removal eradicates the production site of p15E-like factors. This report describes a prospective follow-up study on the levels of bioactive p15E-like serum factors for a period of 2 years in nine patients with HNSCC who had no recurrence and 11 patients with HNSCC who showed residual or recurrent disease after treatment. In the group of patients without recurrent disease p15E-like bioactivity gradually decreased and eventually became negative. In patients with recurrent/residual disease p15E-like bioactivity remained high or even became positive before or at the time of diagnosing tumour recurrence. This study strongly supports the concept that HNSCC tumours are the production site of p15E-like immuno-suppressive factors and indicates that serum p15E-like factors may be used for future studies on early serum markers for recurrent/residual disease developing in the first year after treatment.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8877195     DOI: 10.1111/j.1365-2273.1993.tb00857.x

Source DB:  PubMed          Journal:  Clin Otolaryngol Allied Sci        ISSN: 0307-7772


  4 in total

1.  In vivo effects of thymostimulin treatment on monocyte polarization, dendritic cell clustering and serum p15E-like trans-membrane factors in operable head and neck squamous cell carcinoma patients.

Authors:  J D Kerrebijn; P J Simons; M Tas; A J Balm; H A Drexhage
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

2.  Comparison of retroviral p15E-related factors and interferon alpha in head and neck cancer.

Authors:  P J Simons; R A Oostendorp; M P Tas; H A Drexhage
Journal:  Cancer Immunol Immunother       Date:  1994-03       Impact factor: 6.968

3.  Anti-inflammatory and vasoprotective activity of a retroviral-derived peptide, homologous to human endogenous retroviruses: endothelial cell effects.

Authors:  George J Cianciolo; Salvatore V Pizzo
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

Review 4.  Cancer Associated Endogenous Retroviruses: Ideal Immune Targets for Adenovirus-Based Immunotherapy.

Authors:  Amaia Vergara Bermejo; Emeline Ragonnaud; Joana Daradoumis; Peter Holst
Journal:  Int J Mol Sci       Date:  2020-07-08       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.